Skip to main content
Veterinary Medicines

Zeronil Combo 402 mg/361.8 mg Spot-on Solution for Extra Large Dogs.

Authorised
  • Fipronil
  • (S)-Methoprene

Product identification

Medicine name:
Zeronil Combo 402 mg/361.8 mg Spot-on Solution for Extra Large Dogs.
PURVISO FLEA 402 MG/361,8 MG SOLUTION POUR SPOT-ON POUR TRES GRANDS CHIENS >40 KG
Active substance:
  • Fipronil
  • (S)-Methoprene
Target species:
  • Dog
Route of administration:
  • Spot-on use

Product details

Active substance and strength:
  • Fipronil
    402.00
    milligram(s)
    /
    1.00
    Pipette
  • (S)-Methoprene
    361.80
    milligram(s)
    /
    1.00
    Pipette
Pharmaceutical form:
  • Spot-on solution
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QP53AX65
Authorisation status:
  • Valid
Authorised in:
  • France
Package description:
  • A white pipette composed of a heat-formed shell of polypropylene/cyclic olefin copolymer/polypropylene layer andpolyethylene/ethylene vinyl alcohol/polyethylene layer.Box with 160 pipettes in individual foil sachets.
  • A white pipette composed of a heat-formed shell of polypropylene/cyclic olefin copolymer/polypropylene layer andpolyethylene/ethylene vinyl alcohol/polyethylene layer.Box with 150 pipettes in individual foil sachets.
  • A white pipette composed of a heat-formed shell of polypropylene/cyclic olefin copolymer/polypropylene layer andpolyethylene/ethylene vinyl alcohol/polyethylene layer.Box with 90 pipettes in individual foil sachets.
  • A white pipette composed of a heat-formed shell of polypropylene/cyclic olefin copolymer/polypropylene layer andpolyethylene/ethylene vinyl alcohol/polyethylene layer.Box with 60 pipettes in individual foil sachets.
  • A white pipette composed of a heat-formed shell of polypropylene/cyclic olefin copolymer/polypropylene layer andpolyethylene/ethylene vinyl alcohol/polyethylene layer.Box with 30 pipettes in individual foil sachets.
  • A white pipette composed of a heat-formed shell of polypropylene/cyclic olefin copolymer/polypropylene layer andpolyethylene/ethylene vinyl alcohol/polyethylene layer.Box with 24 pipettes in individual foil sachets.
  • A white pipette composed of a heat-formed shell of polypropylene/cyclic olefin copolymer/polypropylene layer andpolyethylene/ethylene vinyl alcohol/polyethylene layer.Box with 21 pipettes in individual foil sachets.
  • A white pipette composed of a heat-formed shell of polypropylene/cyclic olefin copolymer/polypropylene layer andpolyethylene/ethylene vinyl alcohol/polyethylene layer.Box with 20 pipettes in individual foil sachets.
  • A white pipette composed of a heat-formed shell of polypropylene/cyclic olefin copolymer/polypropylene layer andpolyethylene/ethylene vinyl alcohol/polyethylene layer.Box with 18 pipettes in individual foil sachets.
  • A white pipette composed of a heat-formed shell of polypropylene/cyclic olefin copolymer/polypropylene layer andpolyethylene/ethylene vinyl alcohol/polyethylene layer.Box with 15 pipettes in individual foil sachets.
  • A white pipette composed of a heat-formed shell of polypropylene/cyclic olefin copolymer/polypropylene layer andpolyethylene/ethylene vinyl alcohol/polyethylene layer.Box with 12 pipettes in individual foil sachets.
  • A white pipette composed of a heat-formed shell of polypropylene/cyclic olefin copolymer/polypropylene layer andpolyethylene/ethylene vinyl alcohol/polyethylene layer.Box with 10 pipettes in individual foil sachets.
  • A white pipette composed of a heat-formed shell of polypropylene/cyclic olefin copolymer/polypropylene layer andpolyethylene/ethylene vinyl alcohol/polyethylene layer.Box with 9 pipettes in individual foil sachets.
  • A white pipette composed of a heat-formed shell of polypropylene/cyclic olefin copolymer/polypropylene layer andpolyethylene/ethylene vinyl alcohol/polyethylene layer.Box with 8 pipettes in individual foil sachets.
  • A white pipette composed of a heat-formed shell of polypropylene/cyclic olefin copolymer/polypropylene layer andpolyethylene/ethylene vinyl alcohol/polyethylene layer.Box with 6 pipettes in individual foil sachets.
  • A white pipette composed of a heat-formed shell of polypropylene/cyclic olefin copolymer/polypropylene layer andpolyethylene/ethylene vinyl alcohol/polyethylene layer.Box with 4 pipettes in individual foil sachets.
  • A white pipette composed of a heat-formed shell of polypropylene/cyclic olefin copolymer/polypropylene layer andpolyethylene/ethylene vinyl alcohol/polyethylene layer.Box with 3 pipettes in individual foil sachets.
  • A white pipette composed of a heat-formed shell of polypropylene/cyclic olefin copolymer/polypropylene layer andpolyethylene/ethylene vinyl alcohol/polyethylene layer.Box with 2 pipettes in individual foil sachets.
  • A white pipette composed of a heat-formed shell of polypropylene/cyclic olefin copolymer/polypropylene layer andpolyethylene/ethylene vinyl alcohol/polyethylene layer.Box with 1 pipette in an individual foil sachet.

Additional information

Entitlement type:
  • Marketing Authorisation
Marketing authorisation holder:
  • Chanelle Pharmaceuticals Manufacturing Limited
Marketing authorisation date:
Manufacturing sites for batch release:
  • Chanelle Pharmaceuticals Manufacturing Limited
Responsible authority:
  • French Agency For Food, Environmental And Occupational Health & Safety
Authorisation number:
  • FR/V/8903169 8/2018
Date of authorisation status change:
Reference member state:
  • Ireland
Procedure number:
  • IE/V/0386/005
Concerned member states:
  • Austria
  • Bulgaria
  • Cyprus
  • Czechia
  • France
  • Greece
  • Hungary
  • Italy
  • Netherlands
  • Poland
  • Portugal
  • Romania
  • Slovakia
  • Spain
  • Sweden

Documents

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
French (PDF)
Published on: 21/05/2025

Combined File of all Documents

English (PDF)
Published on: 13/04/2025
Download

Package Leaflet and Labelling

This document does not exist in this language (English). You can find it in another language below.
French (PDF)
Published on: 21/05/2025